NICE Clears Cosentyx For Psoriasis And Moventig For Constipation
This article was originally published in The Pink Sheet Daily
Executive Summary
Final draft guidance recommends Novartis’s IL-17 inhibitor for use in Britain’s National Health Service if supplied at a discounted price, and AstraZeneca’s peglyated naloxol product.